MADIA will develop a versatile and cost-effective in-vitro tool for early diagnosis of Alzheimer’s and Parkinson’s diseases. Alzheimer’s and Parkinson’s diseases, the two most common neurodegenerative disorder worldwide, are debilitating and largely untreatable conditions that are strongly linked with age.
MADIA Sixth project meeting and Workshop
September 21st every year is World Alzheimer's Day around the world.
We share with you the short film "Ogni giorno" (Every day) by Francesco Felli.
Alzheimer’s is the most common form of dementia, affecting seven million across Europe. The global cost of dementia in 2015 was around US$ 820 billion, meaning that age-related neurodegenerative disease is one of the largest medical and societal challenges faced by our society.